Literature DB >> 21189019

Identifying chelators for metalloprotein inhibitors using a fragment-based approach.

Jennifer A Jacobsen1, Jessica L Fullagar, Melissa T Miller, Seth M Cohen.   

Abstract

Fragment-based lead design (FBLD) has been used to identify new metal-binding groups for n class="Chemical">metalloenzyme inhibitors. When screened at 1 mM, a chelator fragment library (CFL-1.1) of 96 compounds produced hit rates ranging from 29% to 43% for five matrix metalloproteases (MMPs), 24% for anthrax lethal factor (LF), 49% for 5-lipoxygenase (5-LO), and 60% for tyrosinase (TY). The ligand efficiencies (LE) of the fragment hits are excellent, in the range of 0.4-0.8 kcal/mol. The MMP enzymes all generally elicit the same chelators as hits from CFL-1.1; however, the chelator fragments that inhibit structurally unrelated metalloenzymes (LF, 5-LO, TY) vary considerably. To develop more advanced hits, one hit from CFL-1.1, 8-hydroxyquinoline, was elaborated at four different positions around the ring system to generate new fragments. 8-Hydroxyquinoline fragments substituted at either the 5- or 7-positions gave potent hits against MMP-2, with IC(50) values in the low micromolar range. The 8-hydroxyquinoline represents a promising new chelator scaffold for the development of MMP inhibitors that was discovered by use of a metalloprotein-focused chelator fragment library.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21189019      PMCID: PMC3024453          DOI: 10.1021/jm101266s

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  72 in total

1.  A rationalization of the acidic pH dependence for stromelysin-1 (Matrix metalloproteinase-3) catalysis and inhibition.

Authors:  L L Johnson; A G Pavlovsky; A R Johnson; J A Janowicz; C F Man; D F Ortwine; C F Purchase; A D White; D J Hupe
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

2.  Design and therapeutic application of matrix metalloproteinase inhibitors.

Authors:  M Whittaker; C D Floyd; P Brown; A J Gearing
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

3.  From model complexes to metalloprotein inhibition: a synergistic approach to structure-based drug discovery.

Authors:  David T Puerta; Julie R Schames; Richard H Henchman; J Andrew McCammon; Seth M Cohen
Journal:  Angew Chem Int Ed Engl       Date:  2003-08-18       Impact factor: 15.336

4.  Evaluation and binding-mode prediction of thiopyrone-based inhibitors of anthrax lethal factor.

Authors:  Jana A Lewis; John Mongan; J Andrew McCammon; Seth M Cohen
Journal:  ChemMedChem       Date:  2006-07       Impact factor: 3.466

Review 5.  Rational design of non-hydroxamate histone deacetylase inhibitors.

Authors:  Takayoshi Suzuki; Naoki Miyata
Journal:  Mini Rev Med Chem       Date:  2006-05       Impact factor: 3.862

Review 6.  Design of zinc binding functions for carbonic anhydrase inhibitors.

Authors:  Jean-Yves Winum; Andrea Scozzafava; Jean-Louis Montero; Claudiu T Supuran
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

7.  Binding of 2-hydroxypyridine-N-oxide on dicopper(II) centers: insights into tyrosinase inhibition mechanism by transition-state analogs.

Authors:  Eugénie Peyroux; Wadih Ghattas; Renaud Hardré; Michel Giorgi; Bruno Faure; A Jalila Simaan; Catherine Belle; Marius Réglier
Journal:  Inorg Chem       Date:  2009-12-07       Impact factor: 5.165

8.  Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values.

Authors:  Z D Liu; S Piyamongkol; D Y Liu; H H Khodr; S L Lu; R C Hider
Journal:  Bioorg Med Chem       Date:  2001-03       Impact factor: 3.641

9.  Addressing lead toxicity: complexation of lead(II) with thiopyrone and hydroxypyridinethione O,S mixed chelators.

Authors:  Jana A Lewis; Seth M Cohen
Journal:  Inorg Chem       Date:  2004-10-18       Impact factor: 5.165

Review 10.  The evolving field of biodefence: therapeutic developments and diagnostics.

Authors:  James C Burnett; Erik A Henchal; Alan L Schmaljohn; Sina Bavari
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

View more
  45 in total

1.  Potent inhibition of dinuclear zinc(II) peptidase, an aminopeptidase from Aeromonas proteolytica, by 8-quinolinol derivatives: inhibitor design based on Zn2+ fluorophores, kinetic, and X-ray crystallographic study.

Authors:  Kengo Hanaya; Miho Suetsugu; Shinya Saijo; Ichiro Yamato; Shin Aoki
Journal:  J Biol Inorg Chem       Date:  2012-02-05       Impact factor: 3.358

2.  A Bioinorganic Approach to Fragment-Based Drug Discovery Targeting Metalloenzymes.

Authors:  Seth M Cohen
Journal:  Acc Chem Res       Date:  2017-07-17       Impact factor: 22.384

3.  Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors.

Authors:  David P Martin; Seth M Cohen
Journal:  Chem Commun (Camb)       Date:  2012-04-24       Impact factor: 6.222

4.  Metalloprotein-inhibitor binding: human carbonic anhydrase II as a model for probing metal-ligand interactions in a metalloprotein active site.

Authors:  David P Martin; Zachary S Hann; Seth M Cohen
Journal:  Inorg Chem       Date:  2013-05-24       Impact factor: 5.165

5.  Metal-Binding Pharmacophore Library Yields the Discovery of a Glyoxalase 1 Inhibitor.

Authors:  Christian Perez; Amanda M Barkley-Levenson; Benjamin L Dick; Peter F Glatt; Yadira Martinez; Dionicio Siegel; Jeremiah D Momper; Abraham A Palmer; Seth M Cohen
Journal:  J Med Chem       Date:  2019-01-31       Impact factor: 7.446

6.  A noncompetitive inhibitor for Mycobacterium tuberculosis's class IIa fructose 1,6-bisphosphate aldolase.

Authors:  Glenn C Capodagli; Wafik G Sedhom; Mary Jackson; Kateri A Ahrendt; Scott D Pegan
Journal:  Biochemistry       Date:  2013-12-24       Impact factor: 3.162

7.  Identification of 3-hydroxy-1,2-dimethylpyridine-4(1H)-thione as a metal-binding motif for the inhibition of botulinum neurotoxin A.

Authors:  Lucy Lin; Lewis D Turner; Peter Šilhár; Sabine Pellett; Eric A Johnson; Kim D Janda
Journal:  RSC Med Chem       Date:  2020-11-12

8.  Computational exploration of zinc binding groups for HDAC inhibition.

Authors:  Kai Chen; Liping Xu; Olaf Wiest
Journal:  J Org Chem       Date:  2013-04-29       Impact factor: 4.354

9.  Newly Designed Quinolinol Inhibitors Mitigate the Effects of Botulinum Neurotoxin A in Enzymatic, Cell-Based, and ex Vivo Assays.

Authors:  Paul T Bremer; Michael Adler; Cecilia H Phung; Ajay K Singh; Kim D Janda
Journal:  J Med Chem       Date:  2017-01-03       Impact factor: 7.446

10.  Structure-Activity Relationships in Metal-Binding Pharmacophores for Influenza Endonuclease.

Authors:  Cy V Credille; Benjamin L Dick; Christine N Morrison; Ryjul W Stokes; Rebecca N Adamek; Nicholas C Wu; Ian A Wilson; Seth M Cohen
Journal:  J Med Chem       Date:  2018-10-31       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.